Abstract
Purpose
Although it is known that those patients who have developed colorectal cancer (CRC) are at a higher risk to develop metachronous adenoma or CRC, no study has been performed to analyze the relationship between the risk factors and the time course for the formation of postoperative adenoma using survival analysis.
Methods
One hundred seventy-six patients with CRC, who had received surgical resection, were endoscopically followed-up to detect the development of metachronous adenoma or adenocarcinoama. The association between the risk factors such as age, synchronous adenomas with index CRC or other clinicopathological variables and the formation of postoperative adenoma was assessed using the logrank test and the Cox proportional hazard model.
Results
Age over 60, synchronous lesions at the time of surgery for primary CRCs and presence of diabetes mellitus (DM) as the associated disease were positively related to the formation of postoperative adenoma. Among those patients with the three risk factors, only 27.8% remained adenoma-free during 5 years after operation, whereas in the group without any risk factor, it was 90.4%.
Conclusions
From our data, age over 60, synchronous adenomas or CRCs and DM were the potential risk factors for the postoperative formation of adenoma or CRC, and they should be taken into consideration when defining the appropriate interval of postoperative colonoscopy.
Similar content being viewed by others
Reference
Hyodo I, Suzuki H, Takahashi K, Saito Y, Tanaka S, Chiu HM, Kim NK, Li J, Lim R, Villalon A et al (2010) Present status and perspectives of colorectal cancer in Asia: Colorectal Cancer Working Group report in 30th Asia-Pacific Cancer Conference. Jpn J Clin Oncol 40(Suppl 1):i38–43
Cali RL, Pitsch RM, Thorson AG, Watson P, Tapia P, Blatchford GJ, Christensen MA (1993) Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 36:388–393
Bulow S, Svendsen LB, Mellemgaard A (1990) Metachronous colorectal carcinoma. Br J Surg 77:502–505
Lockhart-Mummery HE, Heald RJ (1972) Metachronous cancer of the large intestine. Dis Colon Rectum 15:261–264
Fajobi O, Yiu CY, Sen-Gupta SB, Boulos PB (1998) Metachronous colorectal cancers. Br J Surg 85:897–901
Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW (2005) Colorectal cancer. Lancet 365:153–165
Muto T, Bussey HJ, Morson BC (1975) The evolution of cancer of the colon and rectum. Cancer 36:2251–2270
Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL (1987) Natural history of untreated colonic polyps. Gastroenterology 93:1009–1013
Rex DK, Kahi CJ, Levin B, Smith RA, Bond JH, Brooks D, Burt RW, Byers T, Fletcher RH, Hyman N et al (2006) Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 130:1865–1871
Gervaz P, Bucher P, Neyroud-Caspar I, Soravia C, Morel P (2005) Proximal location of colon cancer is a risk factor for development of metachronous colorectal cancer: a population-based study. Dis Colon Rectum 48:227–232
Kang KJ, Sinn DH, Park SH, Kim JY, Chang DK, Son HJ, Rhee PL, Kim JJ, Rhee JC, Chun HK et al (2010) Adenoma incidence after resection of sporadic colorectal cancer with microsatellite instability. J Surg Oncol 101:577–581
Giovannucci E (2002) Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 31:925–943
Haggar FA, Boushey RP (2009) Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 22:191–197
Nguyen SP, Bent S, Chen YH, Terdiman JP (2009) Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 7:676–681, e671-673
He J, Stram DO, Kolonel LN, Henderson BE, Le Marchand L, Haiman CA (2010) The association of diabetes with colorectal cancer risk: the Multiethnic Cohort. Br J Cancer 103:120–126
Marugame T, Lee K, Eguchi H, Oda T, Shinchi K, Kono S (2002) Relation of impaired glucose tolerance and diabetes mellitus to colorectal adenomas in Japan. Cancer Causes Control 13:917–921
Zhao J, Halfyard B, Roebothan B, West R, Buehler S, Sun Z, Squires J, McLaughlin JR, Parfrey PS, Wang PP (2010) Tobacco smoking and colorectal cancer: a population-based case–control study in Newfoundland and Labrador. Can J Public Health 101:281–289
Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M et al. 2010. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. Journal of Diabetes Investigation 2010.
Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP (2000) American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 88:1739–1757
Balleste B, Bessa X, Pinol V, Castellvi-Bel S, Castells A, Alenda C, Paya A, Jover R, Xicola RM, Pons E et al (2007) Detection of metachronous neoplasms in colorectal cancer patients: identification of risk factors. Dis Colon Rectum 50:971–980
Togashi K, Konishi F, Ozawa A, Sato T, Shito K, Kashiwagi H, Okada M, Nagai H (2000) Predictive factors for detecting colorectal carcinomas in surveillance colonoscopy after colorectal cancer surgery. Dis Colon Rectum 43:S47–53
Arditi C, Gonvers JJ, Burnand B, Minoli G, Oertli D, Lacaine F, Dubois RW, Vader JP, Schussele Filliettaz S, Peytremann-Bridevaux I et al (2009) Appropriateness of colonoscopy in Europe (EPAGE II). Surveillance after polypectomy and after resection of colorectal cancer. Endoscopy 41:209–217
Rodriguez-Moranta F, Salo J, Arcusa A, Boadas J, Pinol V, Bessa X, Batiste-Alentorn E, Lacy AM, Delgado S, Maurel J et al (2006) Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol 24:386–393
Folkerd EJ, Dowsett M (2010) Influence of sex hormones on cancer progression. J Clin Oncol 28:4038–4044
Lointier P, Wildrick DM, Boman BM (1992) The effects of steroid hormones on a human colon cancer cell line in vitro. Anticancer Res 12:1327–1330
Nussler NC, Reinbacher K, Shanny N, Schirmeier A, Glanemann M, Neuhaus P, Nussler AK, Kirschner M (2008) Sex-specific differences in the expression levels of estrogen receptor subtypes in colorectal cancer. Gend Med 5:209–217
Moon CM, Cheon JH, Choi EH, Kim ES, Park JJ, Han SY, Kim DH, Kim TI, Kim WH (2010) Advanced synchronous adenoma but not simple adenoma predicts the future development of metachronous neoplasia in patients with resected colorectal cancer. J Clin Gastroenterol 44:495–501
Tran TT, Naigamwalla D, Oprescu AI, Lam L, McKeown-Eyssen G, Bruce WR, Giacca A (2006) Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo. Endocrinology 147:1830–1837
Koenuma M, Yamori T, Tsuruo T (1989) Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn J Cancer Res 80:51–58
Jenab M, Riboli E, Cleveland RJ, Norat T, Rinaldi S, Nieters A, Biessy C, Tjonneland A, Olsen A, Overvad K et al (2007) Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 121:368–376
Campbell PT, Deka A, Jacobs EJ, Newton CC, Hildebrand JS, McCullough ML, Limburg PJ, Gapstur SM (2010) Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology 139:1138–1146
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kawai, K., Sunami, E., Tsuno, N.H. et al. Polyp surveillance after surgery for colorectal cancer. Int J Colorectal Dis 27, 1087–1093 (2012). https://doi.org/10.1007/s00384-012-1420-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-012-1420-z